Substance P clinical trials
How each study uses Substance P is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Substance P studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Substance P
- 5
Studies by the year they started
6 studies that test it; most in 2011 (1)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 4
Danish Headache Center (2) · GlaxoSmithKline (1) · Northwestern University (1) · University of Edinburgh (1) · Vanilloid Genetics Inc. (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Neurotransmitter Agents source
Studies
Open first, then newest update. How each study uses Substance P is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Substance P-Induced Migraine Attacks Without AuraRecruitingNot applicableDanish Headache CenterNCT06959004Written as Substance P
- Effects of Substance P on Headache Induction in Healthy IndividualsNot yet recruitingNot applicableDanish Headache CenterNCT06632080Written as Substance P
- Substance P Challenge in Healthy ParticipantsCompletedNot applicableGlaxoSmithKlineNCT04676763Written as Substance P
- Neuropeptide Therapy of Recent Onset Type 1 DiabetesStatus unknownPhase 1Vanilloid Genetics Inc.NCT02820558Written as Substance P
- Reduction of IgE Antibody in Human Allergic SubjectsCompletedPhase 1Northwestern UniversityNCT01280149Written as substance P
- Effect of Urocortins in Patients With Heart FailureCompletedNot applicableUniversity of EdinburghNCT01599728Written as Urocortin 2, Urocortin 3 and Substance P
Given beside what is tested · 1 — Substance P is usual care or a partner of the new treatment
Codes
What other systems call Substance P · ClinicalTrials.gg INT008242
- MeSH (NLM) D013373Substance POne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D013373 | Substance P | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.